D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLAN
1926
DELISTED
Anaplan, Inc.
PLAN
| $2.64M | ﹤0.01% |
+67,156
| New | +$2.26M |
|
1927
PUT
Accenture
ACN
$99.9B
| $2.64M | ﹤0.01% |
+15,000
| New | +$2.36M |
|
1928
PUT
Factset
FDS
$9.35B
| $2.63M | ﹤0.01% |
10,600
-27,000
| -72% | -$6.04M |
|
|
CHUY
1929
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $2.63M | ﹤0.01% |
115,555
-48,409
| -30% | -$1.06M |
|
|
ZGNX
1930
DELISTED
Zogenix, Inc.
ZGNX
| $2.63M | ﹤0.01% |
47,813
-8,336
| -15% | -$397K |
|
1931
PUT
Vulcan Materials
VMC
$35.1B
| $2.63M | ﹤0.01% |
22,200
| – | – |
|
1932
WPP
WPP
$4.41B
| $2.62M | ﹤0.01% |
49,613
-112,812
| -69% | -$6.29M |
|
1933
Ethan Allen Interiors
ETD
$583M
| $2.61M | ﹤0.01% |
136,373
-27,895
| -17% | -$533K |
|
1934
Karyopharm Therapeutics
KPTI
$159M
| $2.61M | ﹤0.01% |
29,758
+18,447
| +163% | +$2.04M |
|
1935
PUT
Madrigal Pharmaceuticals
MDGL
$11.4B
| $2.6M | ﹤0.01% |
20,800
+10,000
| +93% | +$1.24M |
|
1936
InflaRx
IFRX
$253M
| $2.6M | ﹤0.01% |
68,901
+53,353
| +343% | +$1.99M |
|
1937
Intuit
INTU
$86.3B
| $2.6M | ﹤0.01% |
9,927
-24,999
| -72% | -$5.78M |
|
1938
Arthur J. Gallagher & Co
AJG
$65.9B
| $2.59M | ﹤0.01% |
33,185
+21,096
| +175% | +$1.63M |
|
1939
Sabra Healthcare REIT
SBRA
$5.38B
| $2.59M | ﹤0.01% |
132,849
-780,962
| -85% | -$14.8M |
|
1940
PUT
International Paper
IP
$22.8B
| $2.57M | ﹤0.01% |
58,714
+2,218
| +4% | +$96.1K |
|
|
AEL
1941
DELISTED
American Equity Investment Life Holding Company
AEL
| $2.57M | ﹤0.01% |
95,085
-1,852
| -2% | -$56.1K |
|
|
MGI
1942
DELISTED
MoneyGram International, Inc. New
MGI
| $2.57M | ﹤0.01% |
1,258,882
-14,084
| -1% | -$32.1K |
|
|
GNMK
1943
DELISTED
GenMark Diagnostics, Inc
GNMK
| $2.57M | ﹤0.01% |
362,148
+9,184
| +3% | +$60.5K |
|
1944
SSR Mining
SSRM
$5.54B
| $2.57M | ﹤0.01% |
202,680
-8,485
| -4% | -$112K |
|
|
SOHU
1945
PUT
Sohu.com
SOHU
$359M
| $2.56M | ﹤0.01% |
154,500
-140,900
| -48% | -$2.72M |
|
|
FLNT
1946
Fluent
FLNT
$104M
| $2.56M | ﹤0.01% |
75,863
+8,065
| +12% | +$238K |
|
1947
Empire State Realty Trust
ESRT
$862M
| $2.55M | ﹤0.01% |
161,540
-95,074
| -37% | -$1.46M |
|
1948
PUT
American Tower
AMT
$81.3B
| $2.54M | ﹤0.01% |
12,900
+2,500
| +24% | +$438K |
|
|
RUTH
1949
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $2.54M | ﹤0.01% |
99,171
+12,326
| +14% | +$301K |
|
1950
PUT
Papa John's
PZZA
$995M
| $2.54M | ﹤0.01% |
47,900
-2,900
| -6% | -$128K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.